Pediatric neuro-Behçet's disease responsive to adalimumab.

Journal Article (Journal Article)

Neurologic manifestations of Behçet's disease (neuro-Behçet's disease) are uncommon, but may cause patients significant morbidity and mortality. Neuro-Behçet's disease is chronic and may be refractory to treatment. We report on a 12-year-old girl with neuro-Behçet's disease that responded to standard doses of subcutaneous adalimumab.

Full Text

Duke Authors

Cited Authors

  • Robinson, AB; Gallentine, WB; Rabinovich, CE

Published Date

  • October 2010

Published In

Volume / Issue

  • 43 / 4

Start / End Page

  • 291 - 293

PubMed ID

  • 20837311

Electronic International Standard Serial Number (EISSN)

  • 1873-5150

Digital Object Identifier (DOI)

  • 10.1016/j.pediatrneurol.2010.04.021


  • eng

Conference Location

  • United States